Bern, August 31st, 2021. The last visit of the last NOSTONE participant took place today. The overall study treatment phase has been now completed, with 93% participants reaching end of study in compliance with the study protocol and only 7% drop outs or lost of view patients. The patients’ commitment […]
Despite the COVID pandemic, over 50% (210) of the NOSTONE participants were able to complete the study as planned. The remaining approximately 200 participants will complete the study over the next few months. The last study visit is planned for the end of August 2021. With a proportion of study […]
On March, 30th 2020 the first NOSTONE participant completed the trial with the last visit and CT-Scan performed at Inselspital. The NOSTONE team takes the opportunity to thank this participant for the three years commitment and also the other participants for their ongoing contribution to the project.
On December 5-6th 2019 , the NOSTONE trial’s team participated at the Annual Meeting of the Swiss Society of Nephrology (SGN-SSN) in Interlaken. The team presented the clinical study at the conference.
On November 5-10th 2019, the NOSTONE trial’s team presented the advancements of the project at the international ASN Kidney Week in Washington, D.C. The trial has attracted the attention of physicians and scientists from all over the world waiting for an answer regarding the best prophylactic therapy for kidney stones. […]
